SM
RNVAZ

Sabby Management’s Rennova Health, Inc. Warrant RNVAZ Stock Holding History

Sabby Management’s Portfolio RNVAZ Stock Details RNVAZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-5,249,822
Closed -$105K – 295
2017
Q1 		$105K Buy
5,249,822
+323,809
+7% +$8.71K 0.01% 237
2016
Q4 		$118K Buy
4,926,013
+1,243,999
+34% +$48.6K 0.01% 264
2016
Q3 		$258K Buy
+3,682,014
New +$313K 0.01% 262

Other funds holding RNVAZ

VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Sabby Management's RNVAZ Position: Q2 2017 in Review

Sabby Management sold out of Rennova Health, Inc. Warrant (RNVAZ) in Q2 2017, closing a stake of 5,249,822 shares — an estimated $105K sold.

Sabby Management first reported a position in RNVAZ in Q3 2016 and held it in 3 quarters. The position peaked at $258K in Q3 2016. 4 funds tracked by Wall St. Rank hold RNVAZ as of Q2 2017.

  • Sabby Management reported no remaining Rennova Health, Inc. Warrant position as of Q2 2017 after selling out during the quarter.
  • Sabby Management sold 5,249,822 Rennova Health, Inc. Warrant shares in Q2 2017, an estimated $105K.
  • Sabby Management first reported a position in Rennova Health, Inc. Warrant in Q3 2016 and held it in 3 quarters.
  • Sabby Management's Rennova Health, Inc. Warrant position peaked at $258K in Q3 2016.
  • 4 funds tracked by Wall St. Rank held Rennova Health, Inc. Warrant as of Q2 2017.

Based on Sabby Management's 13F filing for Q2 2017, filed 14 Aug 2017.